CTRI/2021/04/032726
Completed
未知
A Prospective Observational Multicentric Clinical Trial to evaluate microscopic examination of various clinical samples by Artificial Intelligence based system - AI Microscopy
Sevamob Ventures Limited0 sites1,200 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: D649- Anemia, unspecifiedHealth Condition 2: B359- Dermatophytosis, unspecifiedHealth Condition 3: A159- Respiratory tuberculosis unspecifiedHealth Condition 4: N390- Urinary tract infection, site notspecified
- Sponsor
- Sevamob Ventures Limited
- Enrollment
- 1200
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Inclusion criteria for superficial fungal infections: The patients visiting the skin outpatient department (OPD) in the hospital settings and suspected of fungal infections in skin or hair or nail by the dermatologist.
- •2\.Inclusion Criteria for community acquired lower Urinary Tract Infection (UTI): All the patients of symptomatic UTI ââ?°Â¥18 years old from community with complaints of burning micturition and urgency.
- •And not been admitted into the hospital for more than 48 hours in previous 1 month.
- •3\.Inclusion criteria for Blood smear examination: We will include 400 patients who are coming for routine Complete blood count (CBC) evaluation in haematology unit of Department of Pathology. Consent will be taken from the patient/ patient attendant when they will come for routine CBC in hematology lab.
- •4\.Inclusion criteria for pulmonary tuberculosis: Cases of suspected pulmonary tuberculosis whose sputum samples are submitted for AFB microscopy.
Exclusion Criteria
- •1\.Exclusion criteria for superficial fungal infections: Patients on antifungal therapy (oral as well as topical) for last 2ââ?¬â??3 months. Patients with documented bacterial skin infections.
- •2\.Exclusion Criteria: Patients who had been on antibiotics 2 weeks or earlier prior to the study. Patients on phenazopyridine use in the prior 2 day, or with symptoms or signs of pyelonephritis, recent catheterization, or known anatomic or functional abnormalities of the urinary tract.
- •3\. All the patients of Aplastic anaemia, patients on chemotherapy and radiotherapy.
- •4\. Extra pulmonary tuberculosis, children/patients unable to expectorate sputum, patients unwilling to give consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An Observational, Prospective Multicentre Clinical Study to assess the safety and clinical performance of a New Single-use Negative Pressure Wound Therapy System (PICO 7Y) for the Simultaneous Management of Bilateral Closed Incisions in Oncoplastic Breast Surgery Patientsbreast cancer surgeryOncoplastic breast surgery10006295NL-OMON48115Smith&Nephew, Inc6
Completed
Not Applicable
A clinical study to evaluate HF10™ therapy in patients with chronic intractable leg paiChronic, intractable leg painSigns and SymptomsISRCTN11180496evro Corp121
Completed
Not Applicable
A clinical study to evaluate HF10™ therapy in patients with chronic intractable predominant leg paiChronic, intractable predominant leg painSigns and SymptomsISRCTN11720855evro Corp90
Completed
Not Applicable
A prospective, observational, multicenter clinical investigation evaluating the clinical outcomes of tibial and/or ankle fractures stabilizedby the temporary external fixator Galaxy UNYCO SystemTibial and ankle fracture/s that do not allow immediate definitive treatment and having a regular indication for surgical intervention with a temporary external fixatorDRKS00011523Orthofix Srl28
Not yet recruiting
Phase 2
Effect of Kumarabharana Rasa in children with chronic tonsillitisHealth Condition 1: null- Chronic tonsillitisCTRI/2017/03/008050Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital200